Evidence map›Paper›PMID 30354209›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2018

SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.

Sergiy Sukhanov, Yusuke Higashi, Shaw-Yung Shai, Patricia Snarski, Svitlana Danchuk, Veronica D'Ambra, Michael Tabony, T Cooper Woods, Xuwei Hou, Zhaohui Li and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Receptor Tyrosine Kinase: Still an Interesting Target to Inhibit the Proliferation of Vascular Smooth Muscle Cells.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Annual Report on Sex in Preclinical Studies:Arteriosclerosis, thrombosis, and vascular biology · 2020
    Review
  18. Smooth Muscle Cells in Vascular Remodeling.Arteriosclerosis, thrombosis, and vascular biology · 2019
    Review
  19. PAPP-A and the IGF system in atherosclerosis: what's up, what's down?American journal of physiology. Heart and circulatory physiology · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Sergiy SukhanovFrom the University of Missouri-Columbia School of Medicine (S.S., Y.H., P.S., S.D., X.H., Z.L., B.C., P.D.).
Yusuke HigashiFrom the University of Missouri-Columbia School of Medicine (S.S., Y.H., P.S., S.D., X.H., Z.L., B.C., P.D.).
Shaw-Yung ShaiHeart and Vascular Institute (S.-Y.S., V.D., M.T.), Tulane University School of Medicine, New Orleans, LA.
Patricia SnarskiFrom the University of Missouri-Columbia School of Medicine (S.S., Y.H., P.S., S.D., X.H., Z.L., B.C., P.D.).
Svitlana DanchukFrom the University of Missouri-Columbia School of Medicine (S.S., Y.H., P.S., S.D., X.H., Z.L., B.C., P.D.).
Veronica D'AmbraHeart and Vascular Institute (S.-Y.S., V.D., M.T.), Tulane University School of Medicine, New Orleans, LA.
Michael TabonyHeart and Vascular Institute (S.-Y.S., V.D., M.T.), Tulane University School of Medicine, New Orleans, LA.
T Cooper WoodsDepartment of Physiology (T.C.W.), Tulane University School of Medicine, New Orleans, LA.
Xuwei HouFrom the University of Missouri-Columbia School of Medicine (S.S., Y.H., P.S., S.D., X.H., Z.L., B.C., P.D.).
Zhaohui LiFrom the University of Missouri-Columbia School of Medicine (S.S., Y.H., P.S., S.D., X.H., Z.L., B.C., P.D.).
Atsufumi OzoeGraduate School of Agriculture and Life Sciences, University of Tokyo, Bunkyo-ku, Japan (A.O., S.-I.T.).
Bysani ChandrasekarFrom the University of Missouri-Columbia School of Medicine (S.S., Y.H., P.S., S.D., X.H., Z.L., B.C., P.D.).
Shin-Ichiro TakahashiGraduate School of Agriculture and Life Sciences, University of Tokyo, Bunkyo-ku, Japan (A.O., S.-I.T.).
Patrice DelafontaineFrom the University of Missouri-Columbia School of Medicine (S.S., Y.H., P.S., S.D., X.H., Z.L., B.C., P.D.).
University of Missouri · USTulane University · USThe University of Tokyo · JP

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
Insulin-Like Growth Factor-1and AtherosclerosisR01HL070241 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI PATRICE DELAFONTAINE · 2003 to 2026
$10.1M
ANGIOTENSIN II, IGF-1 AND SKELETAL MUSCLE ATROPHYR01HL080682 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI DELAFONTAINE, PATRICE · 2007 to 2015
$3.3M
12/15-LIPOXYGENASE, INSULIN-LIKE GROWTH FACTOR-1 AND ATHEROSCLEROSISR21HL113705 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI SUKHANOV, SERGIY · 2013 to 2014
$399k
BLRD Research Career Scientist Award ApplicationIK6BX004016 · VA · HARRY S. TRUMAN MEMORIAL VA HOSPITAL · PI Chandrasekar Bysani · 2018 to 2026
–
TRAF3IP2 in Ischemic Heart DiseaseI01BX002255 · VA · SOUTHEAST LOUISIANA VETERANS HEALTH CARE · PI BYSANI, CHANDRASEKAR · 2014 to 2017
–
TRAF3IP2 in Adverse Cardiac Remodeling and Heart FailureI01BX004220 · VA · HARRY S. TRUMAN MEMORIAL VA HOSPITAL · PI BYSANI, CHANDRASEKAR · 2018 to 2021
–
BLRD VA I01 BX002255BLRD VA I01 BX004220BLRD VA IK6 BX004016NHLBI NIH HHS R01 HL070241NHLBI NIH HHS R01 HL080682NHLBI NIH HHS R21 HL113705NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

Objective- IGF-1 (insulin-like growth factor 1) is a major autocrine/paracrine growth factor, which promotes cell proliferation, migration, and survival. We have shown previously that IGF-1 reduced atherosclerosis and promoted features of stable atherosclerotic plaque in Apoe

Indexed as

Plaque, AtheroscleroticPromoter Regions, GeneticActinsAnimalsAortaAortic DiseasesApoptosisAtherosclerosisAutoantigensCell MovementCell ProliferationCells, CulturedCollagenDisease Models, AnimalFemaleFibroblastsActa2 protein, mouseActinsAutoantigensCollagenIgf1r protein, mouseMicrofilament ProteinsMuscle ProteinsProto-Oncogene Proteins c-aktReceptor, IGF Type 1RibonucleoproteinsSS-B Antigentransgelinatherosclerosiscardiovascular diseasesfibroblastsmicemyocytes, smooth muscle

Identifiers

PMID30354209
PMCPMC6287936
OpenAlexW2889533658

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.